A recent investigation by CBC News has revealed that some doctors are taking advantage of a regulatory loophole to prescribe unauthorized peptides to patients, despite Health Canada’s warnings against their use for health and fitness purposes. Peptides, short amino acid chains that support various bodily functions, have gained popularity as fitness influencers endorse them for muscle building, anti-aging, and weight loss.
While approved peptides like insulin and GLP-1 drugs have undergone safety assessments, unauthorized peptide products marketed for wellness purposes lack such evaluations. Despite this, doctors have been found promoting and prescribing Body Protection Compound-157 (BPC-157), an unauthorized peptide known for its alleged benefits in muscle growth and tissue repair.
Health Canada prohibits the sale of BPC-157 as an injectable drug or licensed natural health product but allows its compounding into pill form with a doctor’s prescription. This practice has raised concerns among experts like Timothy Caulfield, who believes that doctors should be cautioning patients about these products rather than endorsing them.
CBC News undercover journalists visited clinics in Ontario and British Columbia where doctors were found promoting unauthorized peptides like BPC-157. The doctors claimed the safety and benefits of these peptides, despite the lack of human clinical studies supporting their efficacy.
Compounding pharmacies can formulate BPC-157 for oral administration or topical use, exploiting a regulatory gap that bypasses the usual drug approval process. Health Canada emphasizes that compounding should not circumvent regulatory oversight but acknowledges the practice within a practitioner-patient relationship.
Experts like Stuart Phillips and Patricia Brubaker have raised concerns about the lack of human trials and scientific evidence supporting the use of BPC-157, highlighting the potential health risks associated with its unregulated promotion and prescription.
The College of Physicians and Surgeons of Ontario and British Columbia, as well as the Ontario College of Pharmacists and College of Pharmacists of British Columbia, have varying responses to the issue, with some emphasizing the importance of evidence-based treatments and safe patient care. Health Canada is investigating websites advertising BPC-157 and unauthorized health products to ensure compliance with regulations.
In conclusion, the promotion and prescription of unauthorized peptides like BPC-157 raise serious ethical and safety concerns, emphasizing the need for greater regulatory oversight and evidence-based medical practices in the healthcare industry.